Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents

Type 2 diabetes mellitus (T2DM) is a recognised risk factor for several cardiovascular (CV) conditions including heart failure (HF). Findings that reflect CV risk associated with T2DM medications have led to regulatory requirement of conducting CV outcome trials (CVOTs) for new antidiabetes drugs. O...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Stefan D. Anker
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/dd839f2ab3bf4e1e9d6388f31d4cd802
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!